Cargando…
Artificial Intelligence Based Cancer Nanomedicine
Nanomedicine is evolving with novel drug formulations devised for multifunctional approaches towards diagnostics ad therapeutics. Nanomedicine-based drug therapy is normally explored at a fixed dose. The drug action is time-dependent, dose-dependent and patient-specific. To overcome challenges of na...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Singapore :
Bentham Science Publishers,
2022.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Mu 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_on1330933226 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 220806s2022 si o ||| 0 eng d | ||
| 040 | |a EBLCP |b eng |c EBLCP |d SFB |d REDDC |d OCLCQ |d OCLCF |d OCLCO | ||
| 019 | |a 1385464997 |a 1388522526 | ||
| 020 | |a 9789815050561 | ||
| 020 | |a 9815050567 | ||
| 035 | |a (OCoLC)1330933226 |z (OCoLC)1385464997 |z (OCoLC)1388522526 | ||
| 050 | 4 | |a R859.7.A78 |b .A785 2022 | |
| 082 | 0 | 4 | |a 610.285 |2 23 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Dilnawaz, Fahima. | |
| 245 | 1 | 0 | |a Artificial Intelligence Based Cancer Nanomedicine |h [electronic resource]. |
| 260 | |a Singapore : |b Bentham Science Publishers, |c 2022. | ||
| 300 | |a 1 online resource (110 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 500 | |a Description based upon print version of record. | ||
| 505 | 0 | |a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- The Need for Artificial Intelligence in Cancer Nanomedicine -- Fahima Dilnawaz1,* -- INTRODUCTION -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Application of Artificial Intelligence for Designing Cancer Nanomedicine -- Fahima Dilnawaz1,* -- INTRODUCTION -- USE OF NANOMATERIALS AND AI IN PRECISION DIAGNOSTICS -- PREDICTION OF PERSONALIZED DRUG POTENCY BY NANOTECHNOLOGY | |
| 505 | 8 | |a UTILIZING COMPUTATIONAL MODELLING IN NANOTHERAPEUTICS FOR TARGETING AND PERSONALIZED DOSING -- UTILIZING AI AND NANOMATERIALS FOR DRUG DOSING AND IMPROVED THERAPEUTIC EFFICACY -- EXPLOITING THE USE OF AI AND NANOTECHNOLOGY FOR PERSONALIZED GENE THERAPY -- CONCLUSION AND FUTURE PERSPECTIVE -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence and its Application in Cancer Nanomedicine -- Sweta Mohanty1, Sarbari Acharya1 and Chandana Mohanty1,* -- INTRODUCTION -- CANCER NANOMEDICINE -- ARTIFICIAL INTELLIGENCE (AI) | |
| 505 | 8 | |a ROLE OF AI IN DRUG DISCOVERY -- APPLICATION OF AI TECHNOLOGIES IN CANCER NANOMEDICINE -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence-based Diagnostic Design for Precision Cancer Nanomedicine -- Ranjita Misra1,* and Malathi Sampath2 -- INTRODUCTION -- ROLE OF NANOMEDICINES IN CANCER DIAGNOSIS -- NANOMEDICINES USED FOR CANCER DIAGNOSIS -- ARTIFICIAL INTELLIGENCE AND ITS SIGNIFICANCE -- APPLICATION OF ARTIFICIAL INTELLIGENCE TOWARDS CANCER DIAGNOSIS -- ADVANTAGE OF INTEGRATION OF ARTIFICIAL INTELLIGENCE AND NANOMEDICINES | |
| 505 | 8 | |a CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence-based Nanosensors to Compose the Patient's Cancer Biomarker Profile -- Malathi Sampath1 and Ranjita Misra2,* -- INTRODUCTION -- NANOSENSORS AND THEIR ROLE IN BIOMARKERS PROFILING -- TYPES OF NANOSENSORS -- Affinity Based Biosensors -- Catalytic Based Sensors -- Enzymes -- Microbes -- Organelles -- Tissue Samples -- OPTICAL NANOSENSORS -- ELECTROCHEMICAL SENSORS -- CHEMICAL NANOSENSORS -- DEPLOYABLE SENSOR -- ELECTROMETERS -- BIOSENSOR | |
| 505 | 8 | |a ADVANTAGES OF AMALGAMATION OF NANOSENSORS WITH ARTIFICIAL INTELLIGENCE -- FUTURE PERSPECTIVES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Artificial Intelligence as a Putative Tool for Newer Drug Development Approach in Cancer Nanomedicine -- Pooja Jain1, Sradhanjali Mohapatra1, Nazia Hassan1, Manvi Singh2, Uzma Farooq1, Mohd. Aamir Mirza1 and Zeenat Iqbal1,* -- INTRODUCTION -- CANCER -- Cancer Diagnosis and Treatment Approaches -- Cancer Nanomedicines -- ARTIFICIAL INTELLIGENCE -- Integration of AI and Nanotechnology for Cancer Therapy | |
| 500 | |a Artificial Intelligence-Driven Approach for Future Healthcare System | ||
| 520 | |a Nanomedicine is evolving with novel drug formulations devised for multifunctional approaches towards diagnostics ad therapeutics. Nanomedicine-based drug therapy is normally explored at a fixed dose. The drug action is time-dependent, dose-dependent and patient-specific. To overcome challenges of nanomedicine testing, artificial intelligence (AI) serves as a helping tool for optimizing the drug and dose parameters. Real time conversions between these two features enables upgradation of patient data acquisition and improved design of nanomaterials. In this scenario, AI-based pattern analysis an. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Artificial intelligence |x Medical applications. | |
| 650 | 0 | |a Cancer |x Treatment. | |
| 650 | 0 | |a Drug delivery systems. | |
| 650 | 0 | |a Nanomedicine. | |
| 650 | 0 | |a Artificial intelligence. | |
| 650 | 0 | |a Computer-aided design. | |
| 650 | 2 | |a Nanomedicine | |
| 650 | 2 | |a Patient-Specific Modeling | |
| 650 | 2 | |a Neoplasms | |
| 650 | 2 | |a Artificial Intelligence | |
| 650 | 2 | |a Computer-Aided Design | |
| 650 | 2 | |a Drug Delivery Systems | |
| 650 | 6 | |a Intelligence artificielle en médecine. | |
| 650 | 6 | |a Cancer |x Traitement. | |
| 650 | 6 | |a Systèmes d'administration de médicaments. | |
| 650 | 6 | |a Nanomédecine. | |
| 650 | 6 | |a Intelligence artificielle. | |
| 650 | 6 | |a Conception assistée par ordinateur. | |
| 650 | 7 | |a artificial intelligence. |2 aat | |
| 650 | 7 | |a computer-aided design (process) |2 aat | |
| 650 | 7 | |a Artificial intelligence |x Medical applications |2 fast | |
| 650 | 7 | |a Cancer |x Treatment |2 fast | |
| 650 | 7 | |a Drug delivery systems |2 fast | |
| 650 | 7 | |a Nanomedicine |2 fast | |
| 700 | 1 | |a Behura, Ajit Kumar. | |
| 776 | 0 | 8 | |i Print version: |a Dilnawaz, Fahima |t Artificial Intelligence Based Cancer Nanomedicine: Diagnostics, Therapeutics and Bioethics |d Singapore : Bentham Science Publishers,c2022 |z 9789815050578 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=7014636 |z Texto completo |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL7014636 | ||
| 994 | |a 92 |b IZTAP | ||